E139 – SGLT2 inhibitors for kidney and heart disease
Sep 19, 2022
13:39
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease. Jo Cheah finds out more from cardiologist John Atherton.
